New York Assembly Bill A136, scheduled to take effect in August 2026, establishes a statutory framework for medical aid in dying (MAID) for eligible patients with terminal illness. This review synthesizes evidence from established U.S. MAID jurisdictions, including Oregon, Washington, California, Colorado, Vermont, and Montana, with emphasis on clinical implementation, ethical considerations, and cardiology-specific challenges. Although MAID legislation has primarily been discussed in oncology and palliative medicine, its implications for patients with advanced cardiovascular disease have received comparatively less attention in the literature. Heart failure is often characterized by fluctuating disease trajectories, recurrent hospitalizations, prognostic uncertainty, and complex decisions involving advanced therapies and implantable cardiac devices, all of which may complicate assessment of eligibility under the law. This narrative review examines the major provisions of A136. It also discusses their relevance to cardiovascular practice, with particular attention to prognostication, informed consent, palliative care integration, clinician responsibilities, and ethical distinctions between MAID and withdrawal of life-sustaining therapies. The review also considers how social determinants of health and disparities in cardiovascular care may influence patient experiences, symptom burden, and end-of-life decision-making. As MAID becomes integrated into clinical practice in New York, cardiologists and multidisciplinary care teams will need to balance legal requirements with careful communication, individualized patient care, and established principles of cardiovascular palliative medicine.
Branigan et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: